SCHEMBL3962124

SCHEMBL3962124

OCC(Nc1cc(-c2cccnc2)nc(-c2ccccn2)n1)c1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.46
NPC1 O15118 2/20 0.43
TP53 P04637 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PKM P14618 1/20 0.43
TSHR P16473 1/20 0.43
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 1/20 0.41
EGFR P00533 1/20 0.40
DHPS P49366 1/20 0.39
CYP1A2 P05177 2/20 0.39
SLC2A1 P11166 1/20 0.39
CYP19A1 P11511 1/20 0.39
TACR3 P29371 1/20 0.38
TRPM8 Q7Z2W7 2/20 0.38
HIF1A Q16665 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2D6 P10635 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766379 0.83 CYP2A6 (0.46) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4766345 0.83 CYP2A6 (0.46) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4774839 0.83 DYRK1A (0.51) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4773536 0.81 CYP2A6 (0.44) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4775017 0.81 CYP2A6 (0.44) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4773513 0.81 CYP2A6 (0.44) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL2241722 0.81 CYP2A6 (0.46) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4773182 0.77 CYP2A6 (0.39) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4773165 0.77 CYP2A6 (0.39) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL3962923 0.76 CYP2A6 (0.43) CYP2A6NPC1TP53RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044056-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS Novartis Ag (CH) 2009-04-08 EP claimed
WO-2008006583-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS NOVARTIS AG (CH) 2008-01-17 WO claimed
EP-2044056-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS Novartis Ag (CH) 2009-04-08 EP disclosed
WO-2008006583-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS NOVARTIS AG (CH) 2008-01-17 WO disclosed